Information
Shingrix is a non-live, recombinant subunit vaccine designed to prevent herpes zoster, more commonly known as shingles, in adults aged 50 years and older. It is administered through intramuscular injection and is recommended as a two-dose series, with the second dose given two to six months after the first. Shingrix works by stimulating the body's immune system to produce a strong and lasting response against the varicella-zoster virus, which is the virus responsible for both chickenpox and shingles. Unlike some other shingles vaccines that are live vaccines, Shingrix is made from a virus component, not a live virus, making it suitable for a broader range of individuals, including those with weakened immune systems. Clinical trials have shown Shingrix to be highly effective in preventing shingles and its complications, offering over 90% efficacy across all age groups studied.
When using SHINGRIX, a vaccine designed to prevent shingles, it's crucial to follow your doctor's instructions closely and read the label that comes with the medicine. While SHINGRIX does not typically impair your ability to drive or operate machinery, it's important to be aware of its side effects. Common side effects include pain and redness at the injection site, muscle pain, tiredness, headache, shivering, fever, and stomach upset. Although rare, more serious side effects can occur, so any unusual symptoms should be reported to your doctor immediately. Additionally, it's vital to inform your healthcare provider about all other medications you are taking, as they can interact with the vaccine. Adhering to these precautions ensures the safest and most effective use of SHINGRIX.